The American Journal of Medicine
Volume 119, Issue 3 , Pages 230-237 , March 2006

Allergic Rhinitis: Treatment Based on Patient Profiles

  • Bruce M. Prenner, MD

      Affiliations

    • Allergy Associates Medical Group, San Diego, Calif
    • Corresponding Author InformationRequests for reprints should be addressed to Bruce Prenner, MD, Allergy Associates Medical Group, Inc., 6386 Alvarado Court, San Diego, CA 92120.
    • ,
  • Eric Schenkel, MD

      Affiliations

    • Valley Allergy and Asthma Treatment Center, Easton, Penn

References 

  1. Dykewicz MS , Fineman S , Skoner DP , et al.  American Academy of Allergy, Asthma, and Immunology   Diagnosis and management of rhinitis (complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology) . Ann Allergy Asthma Immunol . 1998;81:478–518
  2. D’Alonzo GE . Scope and impact of allergic rhinitis . J Am Osteopath Assoc . 2002;102:S2–S6
  3. Salib RJ , Drake-Lee A , Howarth PH . Allergic rhinitis (past, present and the future) . Clin Otolaryngol Allied Sci . 2003;28:291–303
  4. Fineman SM . The burden of allergic rhinitis (beyond dollars and cents) . Ann Allergy Asthma Immunol . 2002;88:2–7
  5. Fireman P . Treatment of allergic rhinitis (effect on occupation productivity and work force costs) . Allergy Asthma Proc . 1997;18:63–67
  6. Marshall PS , O’Hara C , Steinberg P . Effects of seasonal allergic rhinitis on selected cognitive abilities . Ann Allergy Asthma Immunol . 2000;84:403–410
  7. Kremer B , Den Hartog HM , Jolles J . Relationship between allergic rhinitis, disturbed cognitive functions and psychological well-being . Clin Exp Allergy . 2002;32:1310–1315
  8. Hadley JA . Evaluation and management of allergic rhinitis . Med Clin North Am . 1999;83:13–25
  9. Scadding GK , Richards DH , Price MJ . Patient and physician perspectives on the impact and management of perennial and seasonal allergic rhinitis . Clin Otolaryngol Allied Sci . 2000;25:551–557
  10. Ricard N , Kind P , Christian S , Jensen M , Stewart J . Link between patient preferences and treatment outcomes in seasonal allergic rhinitis (an empiric investigation) . Clin Ther . 1999;21:268–277
  11. Roper Public Affairs and Media. Impact of nasal congestion among allergic rhinitis sufferers. July 2004.
  12. Corren J . Allergic rhinitis and asthma (how important is the link?) . J Allergy Clin Immunol . 1997;99:S781–S786
  13. Grossman J . One airway, one disease . Chest . 1997;111:11S–16S
  14. Bousquet J , Van Cauwenberge P , Khaltaev N  Aria Workshop Group  World Health Organization . Allergic rhinitis and its impact on asthma . J Allergy Clin Immunol . 2001;108:S147–S334
  15. Kay GG , Berman B , Mockoviak SH , et al.   Initial and steady-state effects of diphenhydramine and loratadine on sedation, cognition, mood, and psychomotor performance . Arch Intern Med . 1997;157:2350–2356
  16. Ramaekers JG , Uiterwijk MMC , O’Hanlon JF . Effects of loratadine and cetirizine on actual driving and psychometric test performance, and EEG during driving . Eur J Clin Pharmacol . 1992;42:363–369
  17. Greisner WA . Onset of action for the relief of allergic rhinitis symptoms with second-generation antihistamines . Allergy Asthma Proc . 2004;25:81–83
  18. Eisen SA , Miller DK , Woodward RS , Spitznagel E , Przybeck TR . The effect of prescribed daily dose frequency on patient medication compliance . Arch Intern Med . 1990;150:1881–1884
  19. Bousquet J , Van Cauwenberge P , Bachert C , et al.   Requirements for medications commonly used in the treatment of allergic rhinitis . Allergy . 2003;58:192–197
  20. Golightly LK , Greos LS . Second-generation antihistamines (actions and efficacy in the management of allergic disorders) . Drugs . 2005;65:341–384
  21. Meltzer E , Prenner B , Nayak A  Desloratadine Study Group . Efficacy and tolerability of once-daily 5 mg desloratadine, an H1-receptor antagonist, in patients with seasonal allergic rhinitis (assessment during the spring and fall allergy seasons) . Clin Drug Invest . 2001;21:25–32
  22. Berger WE , Schenkel EJ , Mansfield LE  Desloratadine Study Group . Safety and efficacy of desloratadine 5 mg in asthma patients with seasonal allergic rhinitis and nasal congestion . Ann Allergy Asthma Immunol . 2002;89:485–491
  23. Simons FE , Prenner BM , Finn A  Desloratadine Study Group . Efficacy and safety of desloratadine in the treatment of perennial allergic rhinitis . J Allergy Clin Immunol . 2003;111:617–622
  24. Horak F , Stubner UP , Zieglmayer R , Harris AG . Effect of desloratadine versus placebo on nasal airflow and subjective measures of nasal obstruction in subjects with grass pollen-induced allergic rhinitis in an allergen-exposure unit . J Allergy Clin Immunol . 2002;109:956–961
  25. Aaronson DW . Evaluation of cetirizine in patients with allergic rhinitis and perennial asthma . Ann Allergy Asthma Immunol . 1996;76:440–446
  26. Ciprandi G , Cosentino C , Milanese M , Mondino C , Canonica GW . Fexofenadine reduces nasal congestion in perennial allergic rhinitis . Allergy . 2001;56:1068–1070
  27. Corren J , Salmun LM . Quality of life in patients with seasonal allergic rhinitis is improved by desloratadine . [abstract] Allergy . 2000;55:191
  28. Meltzer EO , Casale TB , Nathan RA , Thompson AK . Once-daily fexofenadine HCl improves quality of life and reduces work and activity impairment in patients with seasonal allergic rhinitis . Ann Allergy Asthma Immunol . 1999;83:311–317
  29. Bousquet J , Duchateau J , Pignat JC , et al.   Improvement of quality of life by treatment with cetirizine in patients with perennial allergic rhinitis as determined by a French version of the SF-36 questionnaire . J Allergy Clin Immunol . 1996;98:309–316
  30. Yap YG , Camm AJ . Potential cardiac toxicity of H1-antihistamines . Clin Allergy Immunol . 2002;17:389–419
  31. Casale TB , Blaiss MS , Gelfand E , et al.   First do no harm (managing antihistamine impairment in patients with allergic rhinitis) . J Allergy Clin Immunol . 2003;111:S835–S842
  32. Bachert C , Virchow JC , Plenker A . Desloratadine in the treatment of seasonal allergic rhinitis (results of a large observational study) . Clin Drug Invest . 2002;22:43–52
  33. Gambardella R . A comparison of the efficacy of azelastine nasal spray and loratidine tablets in the treatment of seasonal allergic rhinitis . J Int Med Res . 1993;21:268–275
  34. Charpin D , Godard P , Garay RP , Baehre M , Herman D , Michel FB . A multicenter clinical study of the efficacy and tolerability of azelastine nasal spray in the treatment of seasonal allergic rhinitis (a comparison with oral cetirizine) . Eur Arch Otorhinolaryngol . 1995;252:455–458
  35. Newson-Smith G , Powell M , Baehre M , Garnham SP , MacMahon MT . A placebo-controlled study comparing the efficacy of intranasal azelastine and beclomethasone in the treatment of seasonal allergic rhinitis . Eur Arch Otorhinolaryngol . 1997;254:236–241
  36. Astelin (azelastine hydrochloride) prescribing information . Montvale, NJ: Med Pointe Pharmaceuticals; 2000;
  37. American Academy of Allergy, Asthma and Immunology . Overview of Allergic Diseases (Diagnosis, Management, and Barriers to Care) . Milwaukee, Wisconsin: American Academy of Allergy, Asthma and Immunology; 2000; 1-122
  38. Bachert C , van Cauwenberge P , Khaltaev N , et al.   Allergic rhinitis and its impact on asthma (ARIA) (Executive summary of the workshop report) . Allergy . 2002;57:841–855
  39. Trangsrud AJ , Whitaker AL , Small RE . Intranasal corticosteroids for allergic rhinitis . Pharmacotherapy . 2002;22:1458–1467
  40. Ciprandi G , Canonica WG , Grosclaude M , Ostinelli J , Brazzola GG , Bousquet J . Effects of budesonide and fluticasone propionate in a placebo-controlled study on symptoms and quality of life in seasonal allergic rhinitis . Allergy . 2002;57:586–591
  41. Gawchik S , Goldstein S , Prenner B , John A . Relief of cough and nasal symptoms associated with allergic rhinitis by mometasone furoate nasal spray . Ann Allergy Asthma Immunol . 2003;90:416–421
  42. Mandl M , Nolop K , Lutsky BN  194-079 Study Group . Comparison of once daily mometasone furoate (Nasonex) and fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis . Ann Allergy Asthma Immunol . 1997;79:370–378
  43. Hebert JR , Nolop K , Lutsky BN . Once-daily mometasone furoate aqueous nasal spray (Nasonex) in seasonal allergic rhinitis (an active- and placebo-controlled study) . Allergy . 1996;51:569–576
  44. Fokkens WJ , Cserhati E , dos Santos JM , et al.   Budesonide aqueous nasal spray is an effective treatment in children with perennial allergic rhinitis, with an onset of action within 12 hours . Ann Allergy Asthma Immunol . 2002;89:279–284
  45. Scadding GK , Lund VJ , Jacques LA , Richards DH . A placebo-controlled study of fluticasone propionate aqueous nasal spray and beclomethasone dipropionate in perennial rhinitis (efficacy in allergic and non-allergic perennial rhinitis) . Clin Exp Allergy . 1995;25:737–743
  46. Stern MA , Dahl R , Nielsen LP , et al.   A comparison of aqueous suspensions of budesonide nasal spray (128 micrograms and 256 micrograms once daily) and fluticasone propionate nasal spray (200 micrograms once daily) in the treatment of adult patients with seasonal allergic rhinitis . Am J Rhinol . 1997;11:323–330
  47. Bende M , Carrillo T , Vona I , et al.   A randomized comparison of the effects of budeosinde and mometasone furoate aqueous nasal sprays on nasal peak flow rate and symptoms in perennial allergic rhinitis . Ann Allergy Asthma Immunol . 2002;88:617–623
  48. Day J , Carrillo T . Comparison of the efficacy of budesonide and fluticasone propionate aqueous nasal spray for once daily treatment of perennial allergic rhinitis . J Allergy Clin Immunol . 1998;102:902–908
  49. Dupclay L , Doyle J . Assessment of intranasal corticosteroid use in allergic rhinitis (benefits, costs, and patient preferences) . Am J Manag Care . 2002;8:S335–S340
  50. NASONEX (mometasone furoate monohydrate) nasal spray, 50 μg . [prescribing information] Kenilworth, NJ: Schering-Plough Corporation; 1999;
  51. Nathan RA . Changing strategies in the treatment of allergic rhinitis . Ann Allergy Asthma Immunol . 1996;77:255–259
  52. Berkowitz RB , Bernstein DI , LaForce C , et al.   Onset of action of mometasone furoate nasal spray (NASONEX) in seasonal allergic rhinitis . Allergy . 1999;54:64–69
  53. Meltzer EO , Rickard KA , Westlund RE , Cook CK . Onset of therapeutic effect of fluticasone propionate aqueous nasal spray . Ann Allergy Asthma Immunol . 2001;86:286–291
  54. Gross G , Jacobs RL , Woodworth TH , Georges GC , Lim JC . Comparative efficacy, safety, and effect on quality of life of triamcinolone acetonide and fluticasone propionate aqueous nasal sprays in patients with fall seasonal allergic rhinitis . Ann Allergy Asthma Immunol . 2002;89:56–62
  55. Berger WE , Fineman SM , Lieberman P , Miles RM  Rhinitis Study Groups . Double-blind trials of azelastine nasal spray monotherapy versus combination therapy with loratadine tablets and beclomethasone nasal spray in patients with seasonal allergic rhinitis . Ann Allergy Asthma Immunol . 1999;82:535–541
  56. Ratner PH , van Bavel JH , Martin BG , et al.   A comparison of the efficacy of fluticasone propionate aqueous nasal spray and loratadine, alone and in combination, for the treatment of seasonal allergic rhinitis . J Fam Pract . 1998;47:118–125
  57. Meltzer EO . Clinical evidence for antileukotriene therapy in the management of allergic rhinitis . Ann Allergy Asthma Immunol . 2002;88:23–29
  58. Meltzer EO , Malmstrom K , Lu S , et al.   Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis (a randomized, placebo-controlled clinical trial) . J Allergy Clin Immunol . 2000;105:917–922
  59. Nayak AS , Philip G , Lu S , Malice MP , Reiss TF . Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis (a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall) . Ann Allergy Asthma Immunol . 2002;88:592–600
  60. Pullerits T , Praks L , Ristioja V , Lotvall J . Comparison of a nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitis . J Allergy Clin Immunol . 2002;109:949–955
  61. Jamaleddine G , Diab K , Tabbarah Z , Tawil A , Arayssi T . Leukotriene antagonists and the Churg-Strauss syndrome . Semin Arthritis Rheum . 2002;31:218–227
  62. Theodoropoulos DS , Lockey RF . Allergen immunotherapy (guidelines, update, and recommendations of the World Health Organization) . Allergy Asthma Proc . 2000;21:159–166
  63. Fell WR , Mabry RL , Mabry CS . Quality of life analysis of patients undergoing immunotherapy for allergic rhinitis . Ear Nose Throat J . 1997;76:528–532 534-536
  64. Durham SR , Walker SM , Varga EM , et al.   Long-term clinical efficacy of grass-pollen immunotherapy . N Engl J Med . 1999;341:468–475
  65. Sussman GL , Mason J , Compton D , Stewart J , Ricard N . The efficacy and safety of fexofenadine HCl and pseudoephedrine, alone and in combination, in seasonal allergic rhinitis . J Allergy Clin Immunol . 1999;104:100–106
  66. Schenkel E , Corren J , Murray JJ . Efficacy of once-daily desloratadine/pseudoephedrine for relief of nasal congestion . Allergy Asthma Proc . 2002;23:325–330
  67. McFadden EA , Gungor A , Ng B , et al.   Loratadine/psuedoephedrine for nasal symptoms in seasonal allergic rhinitis (a double-blind, placebo-controlled study) . Ear Nose Throat J . 2000;79:254; 258-260
  68. Grosclaude M , Mees K , Pinelli ME , Lucas M , Van de Venne H . Cetirizine and pseudoephedrine retard, given alone or in combination, in patients with seasonal allergic rhinitis . Rhinology . 1997;35:67–73
  69. Beck RA , Mercado DL , Seguin SM , Andrade WP , Cushner HM . Cardiovascular effects of pseudoephedrine in medically controlled hypertensive patients . Arch Intern Med . 1992;152:1242–1245
  70. Corey JP , Houser SM , Ng BA . Nasal congestion (a review of its etiology, evaluation and treatment) . Ear Nose Throat J . 2000;79:690–693
  71. Joint committee of the American College of Obstetricians and Gynecologoists (ACOG) and the American College of Allergy (ACAAI) . The use of newer asthma and allergy medications during pregnancy . Ann Allergy Asthma Immunol . 2000;84:475–480
  72. Werler MM , Mitchell AA , Shapiro S . First trimester maternal medication use in relation to gastroschisis . Teratology . 1992;45:361–367
  73. McCue JD . Safety of antihistamines in the treatment of allergic rhinitis in elderly patients . Arch Fam Med . 1996;5:464–468
  74. Wilson AM . Are antihistamines useful in managing asthma? . Curr Opin Allergy Clin Immunol . 2002;2:53–59
  75. Grant JA , Nicodemus CF , Findlay SR , et al.   Cetirizine in patients with seasonal rhinitis and concomitant asthma (prospective, randomized, placebo-controlled trial) . J Allergy Clin Immunol . 1995;95:923–932
  76. Baena-Cagnani CE , Berger WE , DuBuske LM , et al.   Comparative effects of desloratadine versus montelukast on asthma symptoms and use of β2-agonists in patients with seasonal allergic rhinitis and asthma . Int Arch Allergy Immunol . 2003;130:307–313
  77. Crystal-Peters J , Crown WH , Goetzel RZ , Schutt DC . The cost of productivity losses associated with allergic rhinitis . Am J Manag Care . 2000;6:373–378
  78. Spaeth J , Klimek L , Mosges R . Sedation in allergic rhinitis is caused by the condition and not by antihistamine treatment . Allergy . 1996;51:893–906
  79. Wilken JA , Kane RL , Ellis AK , et al.   A comparison of the effect of diphenhydramine and desloratadine on vigilance and cognitive function during treatment of ragweed-induced allergic rhinitis . Ann Allergy Asthma Immunol . 2003;91:375–385

PII: S0002-9343(05)00449-3

doi: 10.1016/j.amjmed.2005.06.015

The American Journal of Medicine
Volume 119, Issue 3 , Pages 230-237 , March 2006

Article Tools

* Image Usage & Resolution